Curatolo P, Cusmai R, Trasatti G, Sciarretta A
Riv Neurol. 1985 Nov-Dec;55(6):377-86.
24 patients, ages ranging from 6 months to 14.5 years, affected by epilepsy resistant to common antiepileptic drugs were studied. CDDZ was administered intravenously at doses from 0.5 to 2 mg and EEG was recorded for 45 min (15 min before and 30 after drug administration). In 20 patients the EEGraphic paroxystic activity was modified: in 5 cases a total remission and in 2 cases a partial remission were obtained; in 13 cases the EEG alterations were reduced. Myoclonic petit mal and organic focal seizures were the forms of epilepsy showing the best responses to CDDZ administration. The drug was well tolerated and only in two cases was persistent drowsiness observed for more than six hours, possibly due to concomitant barbiturate therapy.
对24例年龄在6个月至14.5岁之间、对常用抗癫痫药物耐药的癫痫患者进行了研究。静脉注射CDDZ,剂量为0.5至2毫克,并记录45分钟脑电图(给药前15分钟和给药后30分钟)。20例患者的脑电图发作性活动得到改善:5例完全缓解,2例部分缓解;13例脑电图改变减轻。肌阵挛性小发作和器质性局灶性癫痫是对CDDZ给药反应最佳的癫痫类型。该药物耐受性良好,仅在两例中观察到持续嗜睡超过6小时,可能与同时使用巴比妥类药物治疗有关。